Comparison With Observational Methods and Performance Assessment From Real-life Experience of Closed-Loop Insulin Delivery Systems

NCT05932966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 317

Last updated 2024-08-15

No results posted yet for this study

Summary

This study aims to compare glycemic control obtained under closed loop depending on the system : Smartguard (Medtronic 780) versus Control IQ (Tandem) in patients with diabetes type 1.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

Insulin closed-loop delivery system

Insulin closed-loop delivery system

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Coralie AMADOU, PHD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-06
Primary Completion
2024-07-11
Completion
2024-07-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932966 on ClinicalTrials.gov